Blaming Patients: How Failed Treatments Fuel a $51 Billion Brain Device Industry
Washingtoner/10288490

LOS ANGELES - Washingtoner -- The Citizens Commission on Human Rights International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how psychiatry is blaming patients—rather than failed treatments—to justify a surge in brain stimulation interventions. "When psychiatric drugs and therapy don't work, psychiatry rarely blames the treatment—it blames the patient, saying they are 'treatment-resistant,'" said Jan Eastgate, President of CCHR International. "'Treatment-resistant' isn't a diagnosis—it's a deflection. And it's being used to push invasive procedures like Electroconvulsive Therapy (ECT), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), and Transcranial Magnetic Stimulation (TMS)."

These brain stimulation devices were "cleared" by the Food and Drug Administration (FDA) or approved under Humanitarian Device Exemptions, bypassing the rigorous testing normally required of most medical devices. Many were greenlighted based on the device delivering ECT—a practice known for causing brain damage, memory loss, and even death[1].

Even industry insiders acknowledge concerns. "The precise physiological mechanisms of DBS are not yet fully understood," admits one clinical review.[2]  A professor of psychiatry at Brown University's Alpert Medical School, put it more starkly: "This really is a kind of mind control."[3]

The term "treatment-resistant" is a psychiatric sleight of hand, Eastgate says, now used to justify a global neurostimulation industry projected to hit $51 billion by 2030. Labeling up to 60% of psychiatric patients as "resistant" creates a false pretext for experimental interventions.[4] Meanwhile, 25% of patients develop psychotropic drug tolerance within weeks, prompting ever-riskier "solutions."[5]

Electroshock: Psychiatry's Recycled Blunder

ECT involves sending up to 460 volts through the brain to trigger seizures. Contrary to PR spin, Eastgate says, experts report modern ECT is no safer—voltage levels are higher than when broken bones were common due to convulsions.

• FDA Loophole: Grandfathered in without clinical trials in 1976. In 2018, the FDA reclassified some ECT uses as "low risk," even for children as young as 13. Over 2,400 public comments opposed this.
• Global Condemnation: The World Health Organization and United Nations consider ECT on children or the non-consenting a form of torture.[6]
• Medical Harm: Neurologists equate ECT's effects to traumatic brain injury.[7] Patients are 44 times more likely to die by suicide than the general population. One in 15 ECT patients face life-threatening cardiac issues.[8]
• Financial Cost: A $3–5.4 billion industry. Medicaid spent $9 million on ECT in 2023 in 27 states.[9] The VA and Department of Defense have administered it to veterans and children under age five.[10]

Deep Brain Stimulation: Electrodes are surgically implanted into the brain, powered by a device in the chest.

• FDA Fast Track: Approved via Humanitarian Device Exemption for OCD in 2009 without efficacy data.
• Harms: Stroke, hemorrhage, hallucinations, sexual dysfunction, apathy, and suicide attempts.[11]
• Patient Testimonies: Participants in failed DBS trials report cognitive decline and emotional deterioration.[12]

Vagus Nerve Stimulation: Electrical stimulation delivered via electrodes wrapped around the vagus nerve.

• FDA: Approved in 2005 for "treatment-resistant depression" despite lacking robust evidence.
• Risks: Nerve damage, infection, hoarseness, breathing difficulty. The FDA has logged over 10,000 complaints involving death, injury, or device malfunction.[13]
• Cost: Averaging $30,000+.

Transcranial Magnetic Stimulation: Magnetic pulses are aimed at the brain over six weeks.

• Youth Approval: Cleared in 2008 for adults, and in 2024 for adolescents as young as 15.
• Side Effects: "Brain fog," seizures, mood swings. One patient said: "This treatment destroyed my life… It gave me false hope."[14]
• Price Tag: Up to $300 per session; full courses can reach $15,000.

Despite the sophistication of these procedures, there is still no objective medical test to diagnose any psychiatric disorder. No blood test. No brain scan. No biomarker.[15]

More on Washingtoner

• TownePlace Suites Prescott Valley, AZ Opens
• SIX7 Introduces Olfactory Neurodesign™ — The First Fragrance System Engineered to Influence Emotion, Memory, and Desire at the Neural Level
• GetKuwa emerging as GCC's #1 trusted online supplement marketplace as shoppers across UAE, Saudi Arabia, Kuwait, Qatar & Oman seek authenticity
• GenesisEdge Society Unveils ΣClipse AI Multi-Agent System Led by Richard Schmidt
• Uk Financial Ltd Provides Investors Of Maya Preferred & Mayacat Instructions For Upcoming First Ever Listing Of Both Erc-3643 "SEC-Ready" Tokens

Dr. Thomas Insel, former director of the National Institute for Mental Health advised: "Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM [Diagnostic and Statistical Manual of Mental Disorders] diagnoses are based on a consensus… not any objective laboratory measure."[16]

"It's not the patient that's resistant—it's the system that's resistant to accountability," Eastgate said. "In any other field, if the intervention failed, the treatment would be reevaluated. But psychiatry doubles down, pushing more dangerous interventions instead."

CCHR urges policy makers to: End all use of ECT and brain stimulation devices for treatment of mental issues, and end ECT's role as a predicate device for newer technologies. And support humane, non-invasive, non-drug, non-brain stimulation solutions that respect patient dignity and avoid neurological and other physical harm.

CCHR, established in 1969 by the Church of Scientology and psychiatrist Dr. Thomas Szasz has a record of reforms that include banning lethal Deep Sleep Treatment, outlawing ECT use on children in several U.S. states, and securing global recognition for patient rights. Today, the United Nations and WHO echo what CCHR has long fought for: coercion has no place in mental health care.

Sources:

[1] FDA, Final Rule on Electroconvulsive Therapy Devices, Federal Register, Dec. 26, 2018; WHO-OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, p. 58, www.ohchr.org/sites/default/files/documents/publications/WHO-OHCHR-Mental-health-human-rights-and-legislation_web.pdf

[2] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025

[3] Lavanya P. Sharma, et. al, "Deep brain stimulation – A primer for psychiatrists," Asian Journal of Psychiatry, Vol. 104, Feb. 2025

[4] "Treatment resistance in psychiatry: state of the art and new directions," Mol Psychiatry, July 2021, pmc.ncbi.nlm.nih.gov/articles/PMC8960394/#fn-group1

[5] pmc.ncbi.nlm.nih.gov/articles/PMC9332474/

[6] WHO- OHCHR, "Guidance on Mental Health, Human Rights and Legislation," 9 Oct. 2023, pp. 15, 58 and 59; www.cchrint.org/2023/09/18/who-guideline-condemns-coercive-psychiatric-practices/

[7] "Electroconvulsive Shock Therapy Lawsuit – What You Should Know About ECT," www.wisnerbaum.com/defective-medical-device-injuries/ect/

[8] www.cchrint.org/2024/11/08/veterans-day-cchr-calls-for-safeguards/, Peter Simons, "ECT Does Not Seem to Prevent Suicide," Mad In America, 17 Feb. 2023, www.madinamerica.com/2023/02/ect-does-not-seem-to-prevent-suicide/

More on Washingtoner

• Tacoma Creates 2024-2025 Annual Report Highlights Expanded Access to Arts and Culture Across Tacoma
• Kaufman Development and Daniel Kaufman Ventures Announce Strategic Expansion Into Data Centers and AI Infrastructure Across the United States
• Tacoma: City Council Presented with Community Safety Action Strategy Built on Community Input
• City Council Presented With 'Tacoma 2035'
• Bent Danholm Lists Modern Lakefront Estate in Winter Garden's Twinwaters Community

[9] www.cchrint.org/2024/08/23/the-collapse-of-electroshock/ Based on Freedom of Information Requests to 27 states

[10] www.cchrint.org/2018/10/12/veterans-get-damaging-mental-health-deal/; Tricare Encounter Data (TED) Non-Institutional (Outpatient) for Purchased Care claims, Data Extract as of 10/21/2016, Data received from CCHR International Freedom of Information Request, 2016

[11] "Brain Stimulation Therapies," NIMH, www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml, accessed 21 Feb. 2011; Dr. Ananya Mandal, MD, "Deep Brain Stimulation Side Effects," News Medical Life Sciences, 22 July 2023, www.news-medical.net/health/Deep-Brain-Stimulation-Side-Effects.aspx

[12] Danielle Egan, "Adverse Effects: The Perils of Deep Brain Stimulation for Depression," Mad in America, 24 Sept. 2015

[13] www.hg.org/legal-articles/patients-with-complications-from-cyberonics-vns-therapy-systems-may-qualify-to-file-a-lawsuit-49467

[14] FDA MAUDE report, Neurostar TMS, 07/14/2021, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=15283600&pc=OBP

[15] www.sciencedaily.com/releases/2020/08/200817104247.htm

[16] psychrights.org/2013/130429NIMHTransformingDiagnosis.htm